Organization and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share

Potentially dilutive securities not included in the calculation of diluted net loss per share because to do so would be anti-dilutive are as follows (in common stock equivalents):

	Nine Months Ended September 30,
	2022		2021
Common stock warrants		—		717,674
Common stock options		2,718,930		960,402
Restricted stock units		629,007		1,592,796
ESPP shares		115,783		4,109
Total		3,463,720		3,274,981